Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Coherus BioSciences, Nasdaq: CHRS, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 10:50 a.m. EST / 7:50 a.m. PST. The audio presentation can be accessed on the company's investor website. Coherus specializes in commercial-stage biosimilars aimed at enhancing access to impactful therapeutics while delivering healthcare savings.

REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the virtual 39^th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. EST / 7:50 a.m. PST.

The audio portion of the Company presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com.

About Coherus BioSciences, Inc.

Coherus is a leading commercial-stage biosimilar company dedicated to expanding access to high-quality therapeutics that can have a major impact on patients’ lives and to delivering significant savings to the health care system. For additional information, please visit www.coherus.com.

FAQ

When is Coherus BioSciences presenting at the J.P. Morgan Healthcare Conference?

Coherus BioSciences will present on January 11, 2021, at 10:50 a.m. EST / 7:50 a.m. PST.

Where can I listen to the presentation of Coherus BioSciences at the conference?

The audio of the presentation will be available on the Coherus investors page at their website.

What is Coherus BioSciences' focus as a company?

Coherus BioSciences is focused on expanding access to high-quality biosimilars that benefit patients and the healthcare system.

What stock symbol represents Coherus BioSciences?

The stock symbol for Coherus BioSciences is CHRS.